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INTRODUCTION
Non-selective cation channels have been implicated in vasoconstrictor actions as a mechanism for regulating Ca 2+ entry in vascular smooth-muscle cells. Ca 2+ entering the cytosol through these channels may directly activate cell contraction, and the inward current carried by Ca 2+ and Na + may contribute to membrane depolarization for the activation of Ca 2+ entry through L-type voltage-sensitive Ca 2+ channels. We have demonstrated previously that AVP ([Arg 8 ]-vasopressin) elicits distinct Ca 2+ signalling patterns depending on its concentration [1, 2] . Ca 2+ spiking involving L-type voltage-sensitive Ca 2+ channels predominates at the low concentrations of AVP found in the systemic circulation [2] . The roles of non-selective cation channels in these effects of AVP are yet to be examined. It will be important to elucidate the ionic mechanisms governing AVP-stimulated Ca 2+ -entry pathways to understand further their physiological functions. Ca 2+ entry, presumably through non-selective cation channels, has been studied in A7r5 vascular smooth-muscle cells using Ca 2+ -sensitive fluorescent indicators in cells treated with nimodipine or verapamil to exclude contributions of L-type Ca 2+ channels [1, [3] [4] [5] [6] . Byron and Taylor [1] identified two distinct pathways for Ca 2+ entry activated by AVP in A7r5 cells: a CCE (capacitative Ca 2+ -entry) pathway activated by the depletion of intracellular Ca 2+ stores and an NCCE (non-capacitative Ca 2+ -entry) pathway activated specifically by AVP and with differing ionic permeabilities when compared with CCE. Recent studies by Moneer et al. [3, 6] have suggested that AVP activates the NCCE pathway while simultaneously inhibiting the CCE pathway.
In the present study, we have examined the electrophysiological correlation of CCE by studying the store-operated current I SOC and its regulation by AVP. We find that I SOC is activated by AVP in a manner that is not consistent with the reciprocal regulation proposed by Moneer and Taylor [3] . It should be noted that several results of Moneer et al. [3, 6] differ from or directly contradict earlier results from the same laboratory. For example: (i) Byron and Taylor [1] demonstrated that AVP had no effect on capacitative Mn 2+ entry, but Moneer and Taylor [3] reported that AVP inhibits capacitative Mn 2+ entry by as much as 90 %; (ii) Broad et al. [4] reported that arachidonic acid had no effect on capacitative Mn 2+ entry, whereas Moneer and Taylor [3] found that arachidonic acid inhibits CCE; (iii) Byron and Taylor [1] demonstrated that [Ca 2+ ] i responses to [AVP] 50 nM exhibited little plateau phase, whereas a pronounced and sustained increase of [Ca 2+ ] i (∼ 300 nM above resting levels) is apparent in the results of Moneer and Taylor [3] ; (iv) Byron and Taylor [1] found, using both cell populations and single cells, that AVP enhances Ba 2+ entry beyond that stimulated by maximal store depletion, but Moneer and Taylor [3] reported that capacitative Ba 2+ entry was decreased by AVP. Because of the above-noted contradictions in the previous studies and because our electrophysiological results did not fit the reciprocal regulation model, we used fura 2 fluorescence methods to re-examine the CCE pathway and its regulation in A7r5 cells. Our present findings are consistent with the original findings of Byron and Taylor [1] and also support their conclusions that AVP directly activates an NCCE pathway that is relatively impermeable to Mn 2+ and that AVP does not inhibit CCE [1] . The differences between the results of Moneer et al. [3, 6] and our present and previous findings are discussed.
EXPERIMENTAL

A7r5 cell culture
A7r5 cells were propagated from low-passage stocks used in the studies of Byron and Taylor [1, 7] and cultured as described 1 To whom correspondence should be addressed (email kbyron@lumc.edu).
previously [8] . Cells were subcultured on to rectangular (9 mm × 22 mm, no. 1 1 / 2 ) glass coverslips or plastic tissue culture flasks (Corning, Acton, MA, U.S.A.). For fura 2 fluorescence measurements, confluent cell monolayers grown on glass coverslips were used 2-5 days after plating. For electrophysiological recordings, cells grown on plastic were trypsinized (0.25 % trypsin and 1 % EDTA) and replated on 12 mm round glass coverslips. Cells were allowed to adhere for approx. 15 min and then transferred on to external solution for 30 min to 2 h before recording.
Patch-clamp
Whole-cell perforated-or ruptured-patch configurations were used to measure membrane currents under voltage-clamp conditions in single A7r5 cells. All experiments were performed at room temperature (23) (24) (25) • C) with continuous perfusion of external solution (perfusion rates of 1 ml/min; ∼ 0.7 ml chamber volume).
The A well-accepted characteristic of I SOC is that it is inhibited by lanthanides such as Gd 3+ . CCE in A7r5 cells is also reportedly inhibited by low concentrations of Gd 3+ (< 5 µM [3, 4, 6] ). To demonstrate the Gd 3+ sensitivity of I SOC in A7r5 cells, we added 100 µM GdCl 3 to the external solution at the end of the experiment (e.g. Figures 1G, 2A and 2B ). We estimate that the final concentration of free Gd 3+ is in the 1-5 µM range (calculated with WINMAXC software using Gd-aspartate binding constants kindly provided by C. Patton, Stanford University). Inhibition of the inward current by micromolar free Gd 3+ is consistent with its identification as I SOC and also additionally distinguishes it from Cl − currents, which are generally lanthanide-insensitive [9, 10] . Nimodipine (0.5 µM) was present in all external solutions to inhibit L-type Ca 2+ channels. Spermine chloride (100 µM) was also included to block the Mg 2+ -inhibitable current I MIC [11] . Osmolality of all solutions was adjusted to 270 mosmol/l with D-glucose. For membrane patch perforation, 200 µg/ml amphotericin B in the internal solution was used.
Experiments in whole-cell perforated patch configuration were started with series resistance R s < 30 M ; cells with an abrupt decrease in R s were discarded. Recording of I SOC in ruptured patch configuration was started 30 s after break-in. Voltage-clamp command potentials were generated using an Axopatch 200B amplifier under the control of PCLAMP8 software. Time courses of I SOC development during exposure to 1 and 100 nM AVP, 10 µM CPA (cyclopiazonic acid), 1 µM thapsigargin or cell dialysis with 10 mM internal BAPTA were recorded every 10 s by a ramp voltage protocol (from + 85 to − 115 mV starting from a − 15 mV holding potential). Whole-cell currents were digitized at 10 kHz, filtered at 5 kHz and analysed off-line. Currents were normalized to membrane capacitance. Whole-cell capacitance was compensated. Liquid junction potentials were calculated using junction potential calculator provided by PCLAMP8 software and subtracted off-line. Results are presented as means + − S.E.M.
[Ca
A7r5 cells were grown to confluence on glass coverslips. Coverslips were washed twice with control medium (135 mM NaCl, 5.9 mM KCl, 1.5 mM CaCl 2 , 1.2 mM MgCl 2 , 11.5 mM glucose and 11.6 mM Hepes, pH 7.3) and then incubated in the same medium with 4 µM fura 2/AM (fura 2 acetoxymethyl ester), 0.1 % BSA and 0.02 % Pluronic F127 detergent for 90-120 min at 25-30
• C in the dark. The cells were then washed twice and incubated in the dark in control medium (or pretreated with drugs) for 0.5-5 h before the start of the experiment. Fura 2 fluorescence (at 510 nm) was measured in cell populations with a PerkinElmer LS50B fluorescence spectrophotometer. Background fluorescence was determined at the end of the experiment by quenching the fura 2 fluorescence for 10-15 min in the presence of 1 µM ionomycin and 6 mM MnCl 2 in Ca 2+ -free medium. After background fluorescence was subtracted, the ratio of fluorescence at 340 nm excitation to that at 380 nm was calculated and calibrated in terms of [Ca 2+ ] i as described previously [8] .
Mn
2+ -entry measurements
The rates at which Mn 2+ enters the cells to quench fura 2 fluorescence were measured in cell populations after excitation at 358 nm, the wavelength that was empirically determined to be minimally sensitive to changes in [Ca 2+ ]. Changes in fluorescence intensity were measured while 150 µM MnCl 2 was present in Ca 2+ -free control medium (CaCl 2 was omitted). Rates of fluorescence quench were determined using least-squares linear regression analysis (SigmaPlot 2000 software; SPSS, Chicago, IL, U.S.A.) of the change in emitted fluorescence in 1 min time periods (120 data points). Mn 2+ entry was also measured in individual cells using a microscope-based digital image analysis system (Compix, Cranberry Township, PA, U.S.A.) that allowed for recording from approx. 10-15 cells within the microscope field. Sequential excitation at 340, 359 and 380 nm allowed simultaneous recording of Mn 2+ entry (at 359 nm) and [Ca 2+ ] i (as indicated by changes in the 340:380 fluorescence ratio). All three wavelengths were recorded at acquisition rates of approx. 1 s −1 . Fluorescence intensity in single cells was measured using Compix SimplePCI software. For the analysis of Mn 2+ -entry rates, fluorescence intensity after excitation at 359 nm (F) was normalized to the mean fluorescence recorded for 60 s, just before the addition of MnCl 2 (F 0 ); regression analysis from 2 min periods of normalized fluorescence (F/F 0 ) was used to estimate quench rates. LOE 908 was generously provided by Boehringer Ingelheim Pharmaceuticals (Ridgefield, CT, U.S.A.). Solubilization of LOE 908 was accomplished by preparing a 10 mM stock solution in deionized water and then adding the appropriate volume of this stock to a volume of control medium before adjusting the pH to its final value.
RESULTS
We used electrophysiological techniques to measure I SOC activated by depletion of Ca 2+ stores. As shown in Figure 1 (A), I SOC is activated incrementally by the addition of 1 and 100 nM AVP and it stabilizes after the addition of 10 µM CPA, a reversible inhibitor of the sarco/endoplasmic reticulum Ca 2+ -ATPase. I SOC activity reverses rapidly on washout of CPA ( Figure 1A) . The same inwardly rectifying current developed as a result of passive emptying of Ca 2+ stores with 1 µM thapsigargin (irreversible inhibitor of sarcoplasmic reticulum Ca 2+ -ATPase; Figures 1C and  1D ) or by cell dialysis with 10 mM BAPTA (< 1 nM free Ca 2+ in the pipette) in the ruptured patch configuration ( Figures 1E  and 1F ).
I SOC activated by emptying of Ca 2+ stores with AVP, CPA, thapsigargin or BAPTA have similar current densities measured at − 115 mV (− 0.60 + − 0.10 pA/pF AVP-activated I SOC , n = 6; − 0.49 + − 0.10 pA/pF thapsigargin-activated I SOC , n = 8; − 0.55 + − 0.03 pA/pF BAPTA-activated I SOC , n = 26; − 0.39 + − 0.05 pA/pF CPA-activated I SOC , n = 5), have the same-shaped I-V curves, reversed at the same voltage and were each blocked by Gd 3+ . Replacement of 100 mM NMDG + in the external solution with 100 mM Na + did not alter the reverse potential or current density ( Figure 1G ), suggesting that I SOC is relatively selective for Ca 2+ compared with Na + . In agreement with fura 2 fluorescence measurements of CCE, I SOC is insensitive to 30 µM LOE 908 ( Figure 1H ), a channel-blocking drug that was reported to inhibit NCCE without affecting CCE [3] . On the basis of its activation by treatments that actively or passively deplete intracellular Ca 2+ stores, its ability to conduct Ca 2+ , its sensitivity to µM Gd 3+ and insensitivity to LOE 908, we hypothesize that I SOC corresponds to the CCE pathway identified by fura 2 fluorescence studies.
On the basis of this hypothesis, the reciprocal regulation model of Moneer et al. [3, 6] would predict that I SOC would be active only after AVP removal and that AVP would inhibit thapsigarginactivated I SOC . Using perforated patch whole-cell voltage clamp, we find that I SOC is active in the presence of 100 nM AVP, with no apparent rebound on the removal of AVP (Figure 2A ). We also found that thapsigargin-activated I SOC is not inhibited by 100 nM AVP ( Figure 2B ).
To examine the apparent disagreement between the electrophysiology results and the reciprocal regulation model proposed by Moneer and Taylor [3] , we used fura 2 fluorescence techniques, specifically focusing on the proposed inhibition of CCE by AVP. Previous studies [1] suggested that the CCE pathway is permeable to Mn 2+ , whereas the NCCE pathway does not conduct Mn 2+ . The reciprocal regulation theory [3] would predict that, during AVP exposure, there would be little enhancement of Mn 2+ entry, but a robust increase in Mn 2+ entry after the removal of AVP. We found that Mn 2+ entry was significantly increased in the presence of 100 nM AVP (by 4.5 + − 1.2-fold, n = 4, P < 0.01, paired t test) and there was no rebound of Mn 2+ entry after AVP removal ( Figure 3 ). The AVP-stimulated Mn 2+ entry may be attributed to CCE since (i) it did not require continued receptor activation (the stimulated rate was maintained after the removal of AVP in the Ca 2+ -free medium) and (ii) brief exposure to extracellular Ca 2+ (to refill partially the Ca 2+ stores) significantly decreased the rate of Mn 2+ entry (by 58 + − 4 %, n = 3, P < 0.05; Figures 3B and 3C ).
The question of whether AVP inhibits Mn 2+ entry after store depletion was also re-examined. Mn 2+ entry was measured before or during exposure to CPA; CPA stimulated Mn 2+ entry by 7.4 + − 0.8-fold (n = 3). No change in Mn 2+ entry was observed when AVP (100 nM) was added after the stabilization of CPA-activated Mn 2+ entry (8.0 + − 0.8-fold increase over basal, n = 3, P > 0.5 compared with CPA alone; Figure 4 ). These results are consistent with the conclusion of Byron and Taylor [1] that AVP does not inhibit capacitative Mn 2+ entry, but cannot be readily reconciled with the results of Moneer and Taylor [3] .
A7r5 cells were not derived by cloning [12] and therefore might be expected to display heterogeneity among cells in a population. We used single-cell imaging techniques to examine the heterogeneity of single-cell responses using a pretreatment method established by Byron and Taylor [1] and also used by Broad et al. [4] and Moneer and Taylor [3] . A7r5 cells are pretreated with a combination of ionomycin (1 µM) and thapsigargin (500 nM) to deplete fully the intracellular Ca 2+ stores. The effectiveness of this treatment is demonstrated in Figure 7 (A) where a robust Ca 2+ release response to 100 nM AVP in untreated cells is compared with an undetectable Ca 2+ release in the ionomycin/thapsigarginpretreated cells. Figure 5A , upper panels), which was not altered by the presence of 100 nM AVP. The Ca 2+ -sensitive fluorescence ratio measured in the same cells (340:380; Figure 5A , lower panels) confirms that AVP did not detectably release additional Ca 2+ from intracellular stores. Analysis of 102 cells from four independent experiments indicates that there was no effect of AVP on mean Mn 2+ -entry rates (Figure 5B) . We also examined the distribution of rates among individual cells comparing untreated and AVP-treated groups (Figure 5C ). There was no significant difference in the distribution of rates, although there was a tendency towards a time-dependent decrease in quench rates in the controls, which was decreased by AVP, contrary to the predictions of the reciprocal regulation model.
Results of Broad et al. [4] and Moneer and Taylor [3] Moneer et al. [6] reported that AVP treatment nearly abolishes the Ca 2+ transient that results when extracellular Ca 2+ is reintroduced after the depletion of intracellular Ca 2+ stores. We performed a set of experiments in which intracellular Ca 2+ stores were first depleted with 500 nM thapsigargin and 1 µM ionomycin in Ca 2+ -free medium (a similar method was used by Moneer et al. [6] ). Fura 2 fluorescence ratios were then recorded during the reintroduction of extracellular Ca 2+ (1.5 mM) without or at various times after the addition of 100 nM AVP (Figure 7) . In three sets of experiments, the mean peak [Ca 2+ ] i response was at least 30 % larger, at all time points after AVP addition, compared with the control response measured in the absence of AVP. The enhanced peak is consistent with the activation of an additional Ca 2+ -entry pathway (NCCE) by AVP, but inconsistent with the reciprocal regulation model of Moneer et al. [3, 6] .
DISCUSSION
Our present findings confirm earlier results from Byron and Taylor [1] entry, but neither enhances nor inhibits this cation-entry pathway once it has been maximally activated by passive store depletion. We also identify, for the first time in A7r5 cells, the electrophysiological equivalent of CCE, a store-operated cation current, which is activated by AVP or other treatments that result in the depletion of intracellular Ca 2+ stores. This current (I SOC ) behaves in accordance with our fluorescence measurements of bivalent cation entry.
In several previous studies [13] [14] [15] [16] , I SOC was not detected in A7r5 cells despite abundant evidence that CCE could be detected using fura 2 fluorescence. Iwamuro et al. [13] , Iwasawa et al. [14] , Jung et al. [15] and Nakajima et al. [16] failed to detect I SOC at steady − 40 to − 60 mV holding potential in external solutions containing 0.2-1.8 mM Ca 2+ . We were also unable to detect I SOC under these conditions (results not shown). However, methods similar to those that we have used in the present study have been used by other investigators to detect store-operated currents in vascular smooth-muscle cells [17] .
In A7r5 cells, I SOC is a relatively Ca 2+ -selective, inwardly rectifying, Gd 3+ -sensitive cation current (Figures 1 and 2) , which is distinct from at least two non-selective cation currents that may be detected in these cells (L. I. Brueggemann, L. L. Cribbs and K. L. Byron, unpublished work). Its identification as a store-operated current is based on: (i) its activation by passive store depletion independent of ligand-receptor interactions, e.g. by inhibition of sarco/endoplasmic reticulum Ca 2+ -ATPase with thapsigargin or CPA or by dialysis with 10 mM BAPTA in a ruptured patch configuration; (ii) its pharmacological properties (Gd 3+ sensitivity, LOE 908-insensitivity); and (iii) its ability to conduct Ca 2+ . The pharmacological properties of I SOC are consistent with fura 2 fluorescence measurements of CCE, which demonstrated that CCE was distinguished from NCCE by its sensitivity to low [Gd 3+ ] [4] and its insensitivity to LOE 908 [3] . Its electrophysiological characteristics resemble those of I SOC measured in vascular smooth-muscle cells by other investigators [17, 18] . Furthermore, we found that I SOC is significantly inhibited by treatment with an antisense construct to TRPC1 [19] , a member of the transient receptor potential family of non-selective cation channels, which has been implicated by other investigators as a store-operated Ca 2+ channel in vascular smooth muscles [20, 21] . Activation of I SOC by 100 nM AVP reproducibly reached a peak and then partially inactivated ( Figures 1A and 2A) . No inactivation of I SOC was apparent after it was activated by passive store depletion with thapsigargin, CPA or BAPTA dialysis; nor when AVP was applied after full activation of the current by thapsigargin ( Figure 2B) . A possible explanation for this observation is that partial refilling of the Ca 2+ stores occurs during AVP treatment (this would tend to shut off the store-operated pathway and would not occur with the passive store depletion regimens or when AVP is added during thapsigargin treatment). Receptor desensitization might account for such an observation, but feedback inhibition on entry channels through a signalling pathway is an unlikely explanation because it would be expected to produce inactivation when AVP is added during thapsigargin treatment.
A reciprocal regulation model proposed by Moneer and Taylor [3] predicts that AVP should inhibit I SOC . The activation of I SOC by AVP and the absence of a rebound activation on AVP removal, combined with the observation that AVP did not inhibit thapsigargin-activated I SOC , led us to re-examine the reciprocal regulation model, applying the fura 2 fluorescence methods used in the studies on which the model was based [3] . Our present findings are consistent with earlier studies of AVP-stimulated Ca 2+ entry in A7r5 cells [1, 4, 5] , but cannot be readily reconciled with the results of Moneer and Taylor [3] and Moneer et al. [6] , which suggest that AVP inhibits store-operated Ca 2+ or Mn 2+ entry. We have not been able to reproduce some of the findings of Moneer et al. [3, 6] despite our attempts to mimic as closely as possible the conditions described in their studies. For example, we did not observe any detectable rebound of [Ca 2+ ] i on AVP removal in the presence of LOE 908 ( Figure 6C ), whereas Figure 7 (A) in [3] (Figure 7 ), whereas Figures 3(A) and 3(B) in [6] show that AVP completely abolishes this transient.
These contradictory findings suggest that something was different in the studies of Moneer et al. [3, 6] , but where that difference lies cannot be readily discerned from their description of the experimental design and methods. All of the methods for cell culture and fura 2 fluorescence appear to be essentially the same as those originally described by Byron and Taylor [7] . There were some subtle differences in the experimental design for measuring Mn 2+ entry: in the experiments described by Moneer and Taylor [3] , AVP was present for only 1 min and fluorescence quench rates were determined by regression analysis from only the final 20 s of that treatment. Other experiments by Moneer and Taylor [3] used much longer AVP treatments and indicated that the effects of AVP on CCE persisted for at least 5 min, so it is not clear why such a brief exposure was used for their Mn 2+ -entry measurements. We have found that analysis of longer recordings (1-2 min) are necessary to obtain a linear regression with a correlation coefficient greater than 0.5 (in the present study, we excluded results with fits that did not meet this criterion) and that longer treatments are necessary to obtain stable quench rates (Figure 4 ). There is no evidence from the three earlier studies [1, 4, 5] or the present study that AVP inhibits CCE. In contrast, the results of Moneer et al. indicate that AVP does inhibit CCE. It is possible that the cells that were used by Moneer et al. represent a subpopulation of A7r5 cells with different properties, but the results from our analysis of single-cell responses do not identify any cell with the expected properties within our A7r5 cell population. If the reciprocal regulation phenotype has such a limited expression, the broad applicability of this model postulated by Taylor [22, 23] Reciprocal or co-ordinated regulation of multiple Ca 2+ -entry pathways has been reported in several cell types and involving several agonist-stimulated signalling pathways (see discussion by Moneer and Taylor [3] ). Most convincingly, activation of an NCCE pathway (ARC channels) by muscarinic agonists may be inhibited by sustained Ca 2+ signals derived from store-operated Ca 2+ entry at high agonist concentrations [24, 25] . Our present findings do not rule out the possibility of such a co-ordinate regulation or the possibility that different Ca 2+ -entry pathways may be activated by different concentrations of agonists, as suggested by early studies of AVP effects in A7r5 cells [1, 2, 4] . However, our findings do call into question the notion that CCE is inhibited by AVP in vascular smooth-muscle cells.
Regulation of Ca 2+ entry in vascular smooth-muscle cells is of crucial importance to cardiovascular physiology since it regulates the contractile state of these cells and hence the diameter of blood vessels as a primary determinant of blood flow and blood pressure. Understanding how vasoconstrictor hormones regulate Ca 2+ entry may provide a better understanding of cardiovascular diseases and improved therapeutic tools for the treatment of these diseases. Our findings bring to light a controversy in the literature of this field. Confirmation by independent laboratories may be required before additional weight is given to support or refute the reciprocal regulation model. In addition, new electrophysiological evidence such as that provided in the present study suggests a means to help resolve the controversy and understand the regulation of Ca 2+ entry by vasopressin.
